You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
The development of FastMycoâ¢: A novel isothermal colorimetric assay for the rapid detection of mycoplasma contamination.
SBC: AMELIA TECHNOLOGIES LLC Topic: 300SBIR 2020: 6823823214: The development of FastMyco™: A novel isothermal colorimetric assay for the rapid detection of mycoplasma contamination. The development of FastMyco™: A novel isothermal colorimetric assay for the rapid detectionof mycoplasma contamination. Project Summary/ Abstract(Word Count: 350) Mycoplasma (myco) contamination of mammalian cell lines are recognized as a major contrib ...
SBIR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health -
Preclinical characterization of a novel neuropeptide for inducing "on-demand" voiding
SBC: Dignify Therapeutics LLC Topic: 105PROJECT SUMMARY (ABSTRACT) Spinal cord injury (SCI) affects an estimated 285,000 Americans. Damage to nerves in the spinal cord can result in a loss of voluntary control over bladder and bowel function that often produces both incontinence and retention of urine and stools in the same patient. The standard of care for urine retention is bladder catheterization to void urine, which may produce urin ...
SBIR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health -
SleepFlexTM head and neck exercise program for the treatment of obstructive sleep apnea
SBC: BERENDO SCIENTIFIC LLC Topic: NHLBIWe propose to develop a simple, non-invasive treatment for obstructive sleep apnea (OSA) that uses head and neck exercises to increase oral, pharyngeal, and cervical muscle strength. OSA is a disorder of repeated upper airway obstruction during sleep that is associated with substantial cardiovascular morbidity and mortality, endocrine disturbances, daytime somnolence, decreased quality of life, an ...
SBIR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health -
DFMO Therapy for Polycystic Kidney Disease
SBC: RESILIO THERAPEUTICS LLC Topic: 300Abstract: DFMO Therapy for Autosomal Dominant Polycystic Kidney Disease (ADPKD)ADPKD is an important human disease affecting 600,000 Americans of all racial and ethnic backgrounds and accounts for about 10% of all end-stage renal disease (ESRD). We discovered that immune- based metabolic reprogramming of arginine metabolism in brain disease is based upon an M2-immune signature that is defined, in ...
STTR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health -
Low-Cost, Low-Dose Flat Panel X-ray Detectors with a Novel Semiconductor
SBC: CAPESYM INC Topic: NIBIBProject Summary/Abstract After decades of advances in medical imaging, X-ray based imaging modalities are still the backbone of modern general and targeted diagnostic and therapeutic imaging. With the advent of flat panel detector technology, flat panel X-ray imagers (FPXIs) are now widely used in digital radiography, fluoroscopy, digital tomosynthesis, image-guided radiation therapy, and cone bea ...
SBIR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health -
A Multi-Omic Platform for Polycystic Ovary Syndrome Characterization and Management
SBC: ONEGEVITY HEALTH, LLC Topic: NICHDProject Summary/Abstract Polycystic ovarian syndrome (PCOS) is the most common endocrine disorder in women of reproductive age. Due to the complex nature of PCOS, diagnosis is often delayed and options for treatment and self-management are limited. With recent developments in high-throughput, next- generation and metabolomics technologies, there is now a unique opportunity to utilize a cost- effec ...
SBIR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health -
Novel Class Therapy for IPF
SBC: Covenant Therapeutics LLC Topic: NHLBIIdiopathic pulmonary fibrosis (IPF) is one of the most fatal lung diseases with high mortality and very limited treatment options. Increased production of collagen is found in IPF patients’ lung. Unfortunately current FDA- approved treatments do not stop disease progression. In vitro and in vivo proof-of-concept studies have been completed by our company and demonstrated that inhibiting peptidyl ...
SBIR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health -
DEVELOPMENT AND TESTING OF SUBCUTANEOUS CSD PEPTIDE FORMULATIONS FOR CHRONIC KIDNEY DISEASE
SBC: LUNG THERAPEUTICS INC Topic: 400Project Summary The global prevalence of chronic kidney disease (CKD) is estimated to be greater than 10%, affecting approximately 500 million people around the world, and due to the global type II diabetes epidemic, incidence is expected to rise. CKD-specific treatments do not currently exist. Clinical management focuses primarily on controlling blood pressure using renin–angiotensin system (RA ...
SBIR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health -
Engineering Methylotrophic Yeast for in vivo Production of Deoxysugars from DHAP
SBC: MIDWEST BIOPROCESSING CENTER LLC Topic: 300The goal of this proposal is to develop a fermentation system to produce a variety of rare and deoxysugars using promiscuous DHAP-dependent aldolases. Carbon-carbon bond forming aldolase reactions are of great relevance to the preparation of fine chemicals, intermediates and bioactive chemicals. The aldolase enzymes responsible for this kind of C-C bond formation catalyze an asymmetric aldol conde ...
SBIR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health -
Development of a Digital Monitoring System to Reduce Risk of Hospital-Acquired Pressure Injuries
SBC: OCUVERA LLC Topic: 600Project Summary/Abstract The goal of the proposed SBIR project is to develop, implement, and demonstrate the feasibility of a Digital Pressure Injury Monitoring (DPIM) system to reduce the risk of Hospital-Acquired Pressure Injuries (HAPIs). HAPIs are a common, costly, and serious problem for public health. Ocuvera’s DPIM system will use data from three-dimensional video processing and custom al ...
SBIR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health